Related Experiment Video
Updated: Jan 12, 2026

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
Clinico-Biochemical Profiles and Outcomes in Acute Decompensated Heart Failure
Diksha Gupta1, Sunita Gupta1, Shanker Deep Sondhi1
1General Medicine, Maharishi Markandeshwar Institute of Medical Sciences and Research, Ambala, IND.
Acute decompensated heart failure (ADHF) in India shows diverse profiles between preserved and reduced ejection fraction (EF) groups. Despite differences in risk factors and comorbidities, in-hospital mortality remained similar, highlighting the need for individualized ADHF management.
Area of Science:
- Cardiology
- Internal Medicine
- Clinical Research
Background:
- Acute decompensated heart failure (ADHF) presents a growing global health challenge, particularly in India, with high mortality and hospitalization rates.
- Understanding the distinct characteristics of ADHF based on ejection fraction (EF) is crucial for effective patient management.
Purpose of the Study:
- To compare risk factors, clinical and biochemical profiles, and in-hospital outcomes of ADHF patients with preserved versus reduced ejection fraction (EF) in an Indian population.
- To address a significant gap in Indian data regarding ADHF patient characteristics and outcomes.
Main Methods:
- A cross-sectional observational study involving 100 consecutive adult patients diagnosed with ADHF.
- Exclusion criteria included congenital heart disease, chronic cor pulmonale, and rheumatic heart disease.
- Data collection included detailed history, clinical examination, investigations, and follow-up until discharge or death, analyzed using SPSS v26.0.
Main Results:
- The study population comprised 52% with heart failure with reduced ejection fraction (HFrEF) and 48% with heart failure with preserved ejection fraction (HFpEF), with a mean age of 62.3 years and male predominance.
- Hypertension, obesity, and COPD were more prevalent in the HFpEF group, while anemia and sepsis were common precipitating factors.
- Elevated total leukocyte count (TLC), N-terminal pro-B-type natriuretic peptide (NT-proBNP), serum creatinine, and shock were associated with poorer outcomes, with creatinine being a strong mortality predictor.
Conclusions:
- ADHF patients exhibit diverse clinico-biochemical profiles and a high comorbidity burden, with notable differences between preserved and reduced EF groups.
- In-hospital mortality rates did not significantly differ between the two EF groups.
- Comprehensive risk assessment beyond EF is essential for timely and individualized management strategies in ADHF.
More Related Videos
04:05Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis
Published on: June 30, 2023
10:21Evaluation of Hydration Status by Bioelectrical Impedance Vector Analysis in Patients with Ischemic Heart Disease Undergoing Exercise Stress Test
Published on: September 22, 2023
Related Concept Videos
Heart Failure V: Medical Management
Acute Coronary Syndrome III: Diagnostic Studies
Heart Failure III: Clinical Manifestations
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Heart Failure IV: Classification and Diagnostic Evaluation
Heart Failure II: Pathophysiology